Jesse Neri
Finanzdirektor/CFO bei ROCKWELL MEDICAL, INC.
Vermögen: 50 328 $ am 30.04.2024
Aktive Positionen von Jesse Neri
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ROCKWELL MEDICAL, INC. | Finanzdirektor/CFO | 18.10.2023 | - |
Karriereverlauf von Jesse Neri
Ehemalige bekannte Positionen von Jesse Neri
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ZYLA LIFE SCIENCES | Corporate Officer/Principal | 01.06.2015 | - |
Ausbildung von Jesse Neri
| Villanova University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
| Director of Finance/CFO | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ROCKWELL MEDICAL, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Zyla Life Sciences LLC
 Zyla Life Sciences LLC Pharmaceuticals: MajorHealth Technology Zyla Life Sciences is a commercial-stage company, which focuses on developing, manufacturing and commercializing innovative treatments for pain. It is focused on bringing non-narcotic products and abuse-discouraging formulations of opioids to patients and healthcare providers. The company plans to continue to grow revenue of its seven commercial products, which includes Sprix nasal spray, Vivlodex, Zorvolex, Tivorbex, Indocin suppositories, Indocin oral suspension and oxaydo tablets, and explore business development opportunities. Zyla Life Sciences was founded in August 2013 and is headquartered in Wayne, PA. | Health Technology |
- Börse
- Insiders
- Jesse Neri
- Erfahrung
